HOME
ABOUT US
STRATEGY
TEAM
PORTFOLIO
4BATLE ICAV
NEWSROOM
CONTACT
More
Fellowship of the Royal Society elections
GSK Hands Off Rare Disease Gene Therapy Portfolio to Orchard Therapeutics
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval
Takeda announces its intention to acquire TiGenix
Spark Therapeutics Announces Pricing and First-of-their-kind Patient Access Programs
4BIO Capital participates in $110M Series B Financing of Orchard Therapeutics